IXICO plc (AIM:IXI)
London · Delayed Price · Currency is GBP · Price in GBX 8.10
-0.40 (-4.71%)
Jul 24, 2026, 3:30 PM GMT
IXICO Revenue
IXICO had revenue of 3.95M GBP in the half year ending March 31, 2026, with 55.59% growth. This brings the company's revenue in the last twelve months to 7.28M, up 13.04% year-over-year. In the fiscal year ending September 30, 2025, IXICO had annual revenue of 6.53M with 13.32% growth.
Revenue (ttm)
7.28M
Revenue Growth
+13.04%
P/S Ratio
2.55
Revenue / Employee
92.09K
Employees
79
Market Cap
18.53M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 6.53M | 768.00K | 13.32% |
| Sep 30, 2024 | 5.77M | -899.00K | -13.49% |
| Sep 30, 2023 | 6.67M | -1.98M | -22.89% |
| Sep 30, 2022 | 8.64M | -547.00K | -5.95% |
| Sep 30, 2021 | 9.19M | -342.00K | -3.59% |
| Sep 30, 2020 | 9.53M | 1.97M | 26.07% |
| Sep 30, 2019 | 7.56M | 2.17M | 40.17% |
| Sep 30, 2018 | 5.39M | 1.29M | 31.56% |
| Sep 30, 2017 | 4.10M | 832.00K | 25.46% |
| Sep 30, 2016 | 3.27M | 153.00K | 4.91% |
| Sep 30, 2015 | 3.12M | 3.11M | 31,050.00% |
| Sep 30, 2013 | 10.00K | -3.64M | -99.73% |
| May 31, 2013 | 3.65M | 3.63M | 19,379.62% |
| Sep 30, 2012 | 18.72K | -47.94K | -71.92% |
| Sep 30, 2011 | 66.66K | -630.20K | -90.43% |
| Sep 30, 2010 | 696.85K | -170.57K | -19.66% |
| Sep 30, 2009 | 867.43K | -1.76M | -66.94% |
| Sep 30, 2008 | 2.62M | 740.93K | 39.36% |
| Aug 31, 2006 | 1.88M | -5.50M | -74.49% |
| Aug 31, 2005 | 7.38M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Palatin Technologies | 9.76M |
| SkinBioTherapeutics | 5.23M |
| Arecor Therapeutics | 1.71M |
| Fusion Antibodies | 1.60M |
| Aptamer Group | 1.38M |
| Genflow Biosciences | 585.61K |
| ImmuPharma | -69.96K |